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either gain-of-function (i.e., overexpression of the pro-
tein of interest) or loss-of-function studies (i.e., genetic 
deletion of the gene of interest). The availability of trans-
genic mouse models and gene deletion studies has 
clearly increased our knowledge about the pathophysiol-
ogy of acute pancreatitis and enables us to study and 
confi rm in vitro fi ndings in animal models. In addition, 
transgenic models with specifi c genetic deletion or over-
expression of genes help in understanding the role of 
one specifi c protein in a cascade of infl ammatory pro-
cesses such as pancreatitis where different proteins in-
teract and co-react. This review summarizes the recent 
progress in this fi eld. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 In vivo models are an indispensable addition to in vi-
tro research fi ndings. For translational research with ap-
plications to clinical aspects, a confi rmation of fi ndings 
from cells and bacteria is a prerequisite prior to clinical 
tests. Transgenic animals enable the study of specifi c 
genes (and in consequence, proteins) of interest. The two 
main categories of transgenic animals can be divided into 
gain-of-function (i.e., overexpression of the protein of in-
terest) or loss-of-function models (i.e., genetic deletion of 
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 Abstract 
 The incidence of acute pancreatitis is growing and world-
wide population-based studies report a doubling or tri-
pling since the 1970s. 25% of acute pancreatitis are se-
vere and associated with histological changes of 
necrotizing pancreatitis. There is still no specifi c medical 
treatment for acute pancreatitis. The average mortality 
resides around 10%. In order to develop new specifi c 
medical treatment strategies for acute pancreatitis, a bet-
ter understanding of the pathophysiology during the on-
set of acute pancreatitis is necessary. Since it is diffi cult 
to study the early acinar events in human pancreatitis, 
several animal models of acute pancreatitis have been 
developed. By this, it is hoped that clues into human 
pathophysiology become possible. In the last decade, 
while employing molecular biology techniques, a major 
progress has been made. The genome of the mouse was 
recently sequenced. Various strategies are possible to 
prove a causal effect of a single gene or protein, using 
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the gene of interest). A transgenic mouse or rat has a trans-
gene in addition to its normal complement of genes. A 
transgene is an artifi cial gene cloned by recombinant 
DNA technology and microinjected into fertilized mouse 
or rat eggs. Eggs are transferred into foster mothers for 
gestation. Transgenic progeny are bred to produce a line. 
Transgenes integrate randomly into chromosomal DNA 
and are transmitted as a Mendelian trait. For tissue-spe-
cifi c protein expression, a construct with a specifi c pro-
moter can be used, for example the elastase promoter for 
specifi c expression in exocrine acini. For expressing pro-
teins in a wide variety of tissues, a CMV promoter can be 
used. In addition, our own observations (see below) and 
the data from Natori et al.  [1] showed that using a CMV 
promoter can result in a highly specifi c protein expression 
in exocrine pancreatic acini. Gene-targeted mice are de-
rived from embryonic stem (ES) cells. ES cells are ma-
nipulated in culture by introducing a targeting vector that 
is cloned in the laboratory by recombinant DNA technol-
ogy. The targeting vector DNA precisely replaces a seg-
ment of chromosomal DNA (hence the name ‘gene target-
ing’) in the ES cell. ES cells are injected into a normal 
mouse blastocyst where they mingle with the embryo’s 
cells to form the developing mouse. Up to 100% of the 
resulting mouse chimera can be formed from cells de-
scended from the ES cells. ES cell-derived mouse chime-
ras are bred to normal mice to produce progeny carrying 
the targeted gene which is transmitted as a Mendelian 
trait. The advantage of generating transgenic animals is 
the less time-consuming protocol. The ‘biological effects’ 
of overexpressing a protein are interpretable as gain of 
function except when there is no phenotype obvious. The 
disadvantage of transgenic animals is that the transgene 
can interfere with other genes and therefore interpreta-
 Table 1. Overview of the different cytokines and their effects 
Transgeneity Experimental model Result Group (fi rst author)
IFN- Overexpression Transient upregulation of EGF, TGF- and EGF receptors, fi brosis Arnush, 1996 [38]
IFN- Overexpression and IFN- 
antibody administration
Lowers the mitotic index of pancreatic ducts and islet cells, reduces 
elevated blood glucose levels
Gu, 1995 [39]
TGF- Overexpression Fibrosis, formation of duct-like tubular complexes Ebert, 1999 [46]
Double transgenic for 
TGF- and TGF-1
Overexpression Dramatic decrease of -cells and development of diabetes Sanvito, 1995 [47]
TGF-1 Overexpression Accumulation of extracellular matrix, massive fi brosis, cellular infi ltrates 
of macrophages and neutrophils, inhibition of acinus cell proliferation, 
impaired TGF- signaling, contribution to autoimmune pancreatitis
Vogelmann, 2001 [48], 
Sanvito, 1995 [47],
Lee, 1995 [49],
Hahm, 2000 [43] 
TGF- receptor Overexpression of dominant 
negative mutant from of the
TGF- receptor
Increase in MHC class 2 molecules, increased susceptibility to cerulein-
induced pancreatitis, T- and B-cell hyperactivation, IgG autoantibodies 
against acinar cells and IgM autoantibodies against pancreatic ductal 
epithelial cells, loss of growth inhibitory and gene induction responses
Bottinger, 1997 [50]
IL-1 Homozygous knockout of 
the ICE gene
Increased survival Norman, 1997 [51]
IL-1 receptor IL-1 receptor deletion 30--50% greater levels of IL-1 mRNA in knockouts as compared to 
wild-type animals, attenuated pancreatitis and lower IL-6 levels
Norman, 1995 [52, 53]
IL-6 Pretreatment with an 
anti-IL-6 antibody
Reduces pancreatic edema in mice with a LPS + cerulein-induced 
pancreatitis
Suzuki, 2000 [55]
IL-6 Knockout mouse Higher plasma levels of TNF- and IL-1, higher degree of oxidative 
and nitrosative tissue damage, more severe tissue injury and an 
increased mortality rate
Cuzzocrea, 2002 [56]
IL-10 Knockout mouse, 
KC blockade
No effect on the degree of edema, neutrophil infi ltration and histological 
lung changes, all effects are more severe in knockout animals as 
compared to C57BL/6J mice
Gloor, 1998 [57]
MAPKAP-2 Knockout mouse Drastically reduced IL-6 and TNF- levels in the serum of knockout 
animals and histological protection against pancreatitis 
Tietz, 2004 [58]
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tion can be diffi cult. One of the major problems by gen-
erating knockout animals is that the gene can be lethal or 
that the embryonic development is infl uenced by other 
gene interactions as a result of the missing gene [for de-
tails see  2] . 
 Especially in infl ammatory processes like pancreatitis 
where subsequent processes and cascades are regulated 
by different factors and interacting molecules, in vivo 
models focusing on just a single gain or loss of function 
protein are of great interest. Transgeneities involved and 
studied in pancreatitis focuses on different levels in the 
regulation of secretion in exocrine pancreatic acini. This 
review focuses on the following aspects: 
 Structural proteins are involved in the development 
and maintenance of pancreatitis. Such proteins are regu-
lated by the stimulus-secretion coupling of the single aci-
nus and are touched during the regulation of exocytosis 
in clusters of acini. Examples of genetic deletions within 
two genes encoding for structural proteins, Cx32 and 
ICAM, on amylase secretion are reported. 
 Beside the cell contact proteins,  zymogen granule pro-
teins are involved in exocytosis. The small GTPase 
Rab3D and a new protein, Itmap1, are localized on the 
zymogen granule membrane and affect amylase secre-
tion. 
 Proteases like cathepsin B are believed to be involved 
in intracellular activation of trypsinogen and thereby may 
contribute to development of acute pancreatitis. 
 Induction and colocalization of the stress protein 
Hsp70 with  lysosomes attenuates trypsinogen activation. 
Another  heat-shock protein , Hsp27, which can regulate 
actin polymerization in vitro, also ameliorates acute pan-
creatitis when it is overexpressed and phosphorylated in 
exocrine pancreatic acini. 
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 Fig.1.  Selected variables affecting acute pancreatitis. Gene expression is regulated by NF  B among other tran-
scription factors. Activation of p38 and MAPKAP-2 regulates cytokine levels and therefore infl uences the sever-
ity of pancreatitis. Lysosome and zymogen granula colocalization results in early trypsinogen activation that can 
be inhibited by Hsp70. Cx32 –/–  leads to elevated amylase levels just as Rab3D and Itmap1. Knockout of intercel-
lular adhesion molecules (ICAMs) results in milder pancreatic injury. Disruption of the actin cytoskeleton and 
actin polymerization is protected by overexpression and phosphorylation of Hsp27. 
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 Cytokines are involved in mediating the infl ammatory 
process during pancreatitis and some of them are induced 
and expressed in pancreatic acini. The p38 MAP kinase 
and MAPKAP kinase-2 are important signal transduc-
tion pathways for regulating TNF-  and interleukin 
(IL)-6. Inhibition of TNF-  and other cytokines attenu-
ates acute pancreatitis. An overview of the different cy-
tokines and their effects is given in  table 1 .  Figure 1 shows 
a scheme of the different effector proteins modifi ed in pan-
creatic acini. Their effects are discussed in this review. 
 Role of Cell Contacts in Pancreas 
 The development of edema during pancreatitis has a 
putative impact on the course of the disease. It probably 
interferes with cell-to-cell contacts within the acini. Early 
studies have demonstrated that dispersion of pancreatic 
acinar cells results in loss of secretion  [3, 4] . The fi nding 
that re-establishment of cell-cell contacts promotes basal 
and stimulated secretion indicates that mechanisms, in-
volving cell-cell interactions, participate in the regulation 
of secretion in pancreatic acini  [5] . Direct cell-to-cell 
communication is achieved by gap junctions, which are 
assemblies of transmembrane channels providing a selec-
tive pathway for the transfer of ions and signaling mole-
cules. These channels are formed by a multi-gene family 
of related proteins, referred to as connexins (Cx). Acinar 
cells are coupled through Cx32- and Cx26-formed gap 
junction channels  [ for details, see  6] . To address the ques-
tion of whether a chronic alteration in the extent of such 
cell contacts affects the secretory activity in acinar cells 
in vivo, Chanson et al.  [7] used homozygous Cx32-defi -
cient mice (Cx32 – / – ). These animals were generated by 
targeted homologue recombination  [8] . These Cx32 – / –  
animals showed enhanced serum amylase levels, thereby 
indicating that a lack of Cx32 protein in fact alters the 
function of the exocrine pancreas in vivo. It may well be 
that the extensive coupling normally observed between 
acinar cells mediates an inhibitory effect on secretion 
downregulating the extent of recruitment of acinar cells. 
Partial loss of gap junctional communication in acini of 
these animals decreased this inhibition and resulted in an 
enhanced recruitment of secreting acinar cells. This situ-
ation is refl ected during acute pancreatitis where a loss of 
gap junctions is observed. To further explore the possible 
role of gap junctions during acute pancreatitis in vivo, 
Frossard et al.  [9] studied the course of pancreatitis in 
mice defi cient of connexin 32. These animals showed a 
deleterious course of acute pancreatitis with increased 
necrosis, edema, infl ammation and decreased apoptosis. 
However, Lerch et al.  [10] demonstrated that the disso-
ciation of adherens junctions and the internalization, re-
localization, and reassembly of their major components 
are likely representing a critical biochemical event at cell-
cell contacts during edema formation in cerulein-induced 
pancreatitis in rats. 
 Zymogen Granule Proteins 
 Zymogen granule proteins and Rab proteins are be-
lieved to play an important role in regulated exocytosis 
and disturbances of acinar cell exocytosis may contribute 
to pancreatitis. Small GTP-binding proteins such as 
Rab3D are localized on the zymogen granules  [11] . In 
transgenic animals specifi cally overexpressing Rab3D on 
zymogen granules  [12], a stimulation of permeabilized 
acini with CCK increased the incorporation of radiola-
beled GTP into HA-tagged Rab3D. This indicates that 
Rab3D is involved crucially in stimulated exocytosis. To 
further understand the function of Rab3D in this context, 
Chen et al.  [13] generated adenoviral constructs encoding 
wild-type Rab3D and mutated forms (N135I and T36N 
defi cient in guanine nucleotide binding whereas Q81l was 
defi cient in GTP hydrolysis) and then infected isolated 
mouse acini. While the expression of Rab3D and the mu-
tant Rab3D Q81l had no effect on amylase secretion, the 
Rab3D mutants N135I and T36N functioned as domi-
nant negative mutants and inhibited CCK-induced amy-
lase release by 40–50%. Localization of adenoviral ex-
pressed Rab proteins showed wild-type Rab3D localized 
to zymogen granules whereas the two dominant negative 
mutants did not localize to the granules but primarily to 
the basolateral cell region. This supported an important 
role for Rab3D in regulating the terminal steps of acinar 
exocytosis. Using Western blotting, Ohnishi et al.  [14] 
demonstrated the expression of another Rab protein, 
Rab4, on zymogen granule membranes. The function in 
regulated exocytosis was examined by introducing Rab4 
peptide and Rab4 antibody into permeabilized acini. 
Both Rab4 peptide and antibody enhanced calcium-stim-
ulated amylase from streptolysin O-permeabilized acini, 
suggesting an inhibitory role of Rab4 in exocytosis. 
 Imamura et al.  [15] investigated the function of a nov-
el acinar cell zona pellucida (ZP)1 domain-containing 
protein (Itmap1). This is an integral membrane-associ-
ated protein, prominently expressed in pancreatic acinar 
cells and localized to zymogen granule membranes. Spe-
cifi c roles in epithelial polarity, granule assembly, and 
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mucosal protection have been proposed for these pro-
teins. Still, no functional in vivo  data exist so far. To de-
termine the in vivo function, Itmap1 – / – -defi cient mice 
were generated and the effects were investigated in a se-
cretagogue- and diet-induced pancreatitis model. The 
Itmap1-defi cient mice did not present a phenotype under 
physiological conditions. The granule size and morphol-
ogy of the acini did not differ from Itmap1 wild-type 
mice. However, Itmap1-defi cient mice showed an im-
paired activation of trypsinogen but histologically a more 
severe pancreatitis in both cerulein- and CDE-induced 
pancreatitis accompanied by increased numbers of apop-
totic cells. Western blot analysis revealed no differences 
in the zymogen granule content between Itmap1-defi cient 
and normal mice. This indicated that the decrease in tryp-
sinogen activity is not due to less trypsinogen content in 
the zymogen granules. 
 These data appear controversial but recent data sup-
port the hypothesis that trypsinogen activation is not me-
diated by trypsin itself and that inhibition of trypsin pre-
vents trypsin inactivation and autodegradation  [16, 17] . 
On the other hand, there is evidence that intrapancreatic 
activation of trypsinogen plays a critical role in the ini-
tiation of acute pancreatitis. In in vitro studies, Saluja et 
al.  [18] demonstrated that intra-acinar cell activation of 
trypsinogen and acinar cell injury in response to supra-
maximal secretagogue stimulation was prevented by the 
cell-permeant cathepsin B inhibitor E64d. Investigations 
were performed using this cathepsin B inhibitor under in 
vivo conditions in two independent models of acute ex-
perimental pancreatitis, secretagogue-elicited pancreati-
tis in mice or duct infusion-elicited pancreatitis in rats. 
They showed a marked reduction of intrapancreatic tryp-
sinogen activation and a substantially reduced severity of 
pancreatitis in both models  [19] . Using pharmacological 
compounds to inhibit proteases or kinases always raises 
concerns regarding the specifi city of the observed effects. 
Therefore, investigating the specifi c role of cathepsin B 
in pancreatitis, Halangk et al.  [20] used mice with a ge-
netic deletion of cathepsin B. They found that deletion of 
cathepsin B was associated with an approximately 50% 
reduction in intrapancreatic trypsinogen activation and 
in the severity of pancreatitis. These effects are less pro-
nounced as effects with the antagonist reported by van 
Acker et al.  [19] . It rather likely indicates that addition-
al proteases other than cathepsin B are involved in in-
trapancreatic trypsinogen activation. Nonetheless, se-
lective cathepsin B inhibitors might be of therapeutic 
potential. 
 Heat-Shock Proteins 
 Exposure of organisms to an initial sublethal stress 
leads to the synthesis of heat-shock proteins (Hsps) and 
confers protection against a subsequent more severe 
stress. Hsps are highly conserved, exist in all organisms, 
and are believed to act in part as molecular chaperones. 
In the pancreas, the possible roles for Hsps in physiolog-
ic and pathophysiologic processes have previously been 
reviewed  [ for details, see  21] . The pattern of individual 
pancreatic Hsps induced by cell stress is dependent on 
the type of applied stress (thermal, water immersion, 
etc.), but the overall protective effect against experimen-
tal pancreatitis is consistent. Bhagat et al.  [22] reported 
recently that applying antisense oligonucleotides of Hsp70 
before induction of thermal stress inhibited the upregu-
lated expression of Hsp70 in response to hyperthermia 
while the upregulated expression of Hsp27 in response to 
hyperthermia remained unaffected. In addition, rats ex-
posed to thermal stress were protected in response to ce-
rulein, but that protection was lost when animals were 
given the antisense oligonucleotides before thermal stress. 
These data indicate that Hsp70 plays a critical role in 
mediating protection against pancreatitis gained by ther-
mal stress  [22] . Furthermore, overexpression of Hsp70 in 
the pancreas of transgenic mice ameliorates acute pancre-
atitis and supports the concept of Hsp70 being protective 
against pancreatitis  [23] . The signifi cance of the small 
Hsp27 has so far received little attention in most studies 
but it has been reported to increase during arginine- and 
cerulein-induced pancreatitis  [24] , putatively signaling a 
mechanism of self-protection  [25] . 
 Hsp27 is a phosphorylation-dependent regulator of ac-
tin polymerization. CCK stimulates pancreatic Hsp27 
phosphorylation both in vivo and in vitro  [24, 26] . There-
fore, Hsp27 may also participate in the regulation of the 
actin cytoskeleton during cerulein-induced acute pancre-
atitis. Previously, we showed that overexpression of hu-
man Hsp27 and a mutated form (huHsp27-3D) which 
mimics phosphorylation protects the cell architecture and 
F-actin cytoskeleton changes induced by stimulation with 
supramaximal concentrations of CCK in CHO cells, 
whereas overexpression of a non-phosphorylatable form 
of Hsp27 (huHsp27-3A) failed to achieve such a favorable 
action  [27] . 
 Therefore, investigating the effects of Hsp27 in vivo 
 utilizing a model of secretagogue-induced pancreatitis, 
we generated transgenic mice overexpressing human 
Hsp27 or its mutant forms (huHsp27-3A and huHsp27-
3D) in exocrine pancreatic acini using a CMV promoter. 
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In our study, we provide evidence that overexpression of 
a single heat-shock protein, Hsp27, in the pancreas of 
transgenic mice confers resistance against cerulein-in-
duced pancreatitis in vivo. Transgenic mice expressing 
huHsp27 or the mutant form huHsp27-3D which mimics 
phosphorylation of Hsp27 showed a reduced activation 
of intrapancreatic trypsinogen, reduced serum lipase and 
amylase levels. Furthermore, less intracellular damage 
and infl ammation occurred. A grossly preserved actin cy-
toskeleton was seen. No protective effects were found in 
animals expressing the huHsp27-3A mutant. However, 
the exact molecular protection mechanism of Hsp27 is 
still unclear but clearly it exerts its effect by preserving 
the F-actin microfi laments and inhibiting actin redistri-
bution  [28] . 
 Cytokines and Pancreatitis in Transgenic 
Animal Models 
 Infl ammatory effects play an important role in the 
pathogenesis of pancreatitis although the exact mecha-
nisms that cause the infl ammatory and necrotizing pro-
cess are only beginning to emerge. Cytokines mediate del-
eterious events in the pancreas as well as in associated 
systems resulting in complications like lung injury and 
multiple organ dysfunction syndrome (MODS). Current 
concepts on cytokines and acute pancreatitis are reviewed 
in Brady et al.  [29] and Schmid and Adler  [30] . 
 A candidate mediator of the infl ammatory response in 
acute pancreatitis is the transcription factor nuclear fac-
tor-  B (NF  B). It has been found that activation of NF  B 
occurs early within acinar cells in the course of acute ex-
perimental pancreatitis  [31, 32] and is correlated with the 
expression of cytokines and chemokines  [33, 34] . How-
ever, the specifi c role of NF  B during onset of pancreati-
tis (i.e., proinfl ammatory or protective) is currently un-
known and controversial  [35] . Details have recently been 
reviewed by Algül et al.  [36] . To further explore the role 
of NF  B, Chen et al.  [37] used adenoviral-mediated 
transfer in isolated acinar cells. Administration of Adp65 
caused activation of NF  B and the expression of NF  B 
target genes. It increased the infi ltration of neutrophils to 
the pancreas and lung and caused damage to pancreatic 
acinar cells. Co-administration of Adp65 with the inhib-
itory subunit I  B-  reduced the level of NF  B activation 
and the infl ammatory response. These data strongly sug-
gest that activation of NF  B in pancreatic acinar cells is 
a major proinfl ammatory factor in acute pancreatitis. 
 Several studies were performed focusing on a variety 
of cytokines: An overview of genetically altered mice and 
the effects on cytokines in acute experimental pancreati-
tis models are shown in  table 1 . 
 Interferon-  (IFN-  ) expression in the pancreas causes 
islet cell destruction, hyperglycemia and initiates infl am-
mation. Overexpression of IFN-  in mice leads to a tran-
sient upregulation of EGF, TGF-  and the EGF receptor. 
In addition, transgenic IFN-  mice have the unique ca-
pacity to regenerate from proliferating ducts. These cyto-
kines are probably involved in mediating the regenerative 
changes leading to fi brosis that resemble those observed 
in chronic pancreatitis  [38] . In a study investigating the 
patterns of proliferation and differentiation of pancreatic 
tissue, Gu et al.  [39] show that treatment of IFN-  mice 
with an IFN-  antibody not only reduces elevated blood 
glucose levels but also lowers the mitotic index of pancre-
atic ducts and islet cells. 
 Transforming growth factors such as TGF-  play a role 
in differentiation and tissue repair  [40] . Altered expres-
sion of this cytokine is found in a variety of pathological 
stages like autoimmune diseases, carcinogenesis, fi brosis 
and chronic infl ammation  [41–43] . Expression of TGF-  
is detected in normal human pancreas. TGF-  overex-
pression is found in the pancreas of patients with chron-
ic pancreatitis  [44] . The infl uence of TGF-  on fi brosis 
was already mentioned by Bockman and Merlino  [45] in 
1992, reporting that TGF-  transgenic mice undergo 
marked fi brosis. The formation of duct-like tubular com-
plexes in TGF-  overexpressing mice is associated with 
increased TFF peptide (formerly called trefoil factors or 
P-domain peptide) expression  [46] . A double transgenic 
breading for TGF-  and TGF-  1  leads to a dramatic de-
crease of   -cells and the development of diabetes mellitus 
within 4 months  [47] . TGF-  1  overexpression alone leads 
to a progressive accumulation of extracellular matrix 
 [48] , ultimately resulting in massive fi brosis  [47] . This 
process is accompanied by cellular infi ltrates comprising 
macrophages and neutrophils. It inhibits the proliferation 
of acinar cells  [49] . Opposed to the deleterious effects of 
TGF-  1  overexpression, Hahm et al.  [43] showed that 
TGF-  is essential for normal immune homeostasis and 
protective against autoimmunity. Impaired TGF-  sig-
naling contributes to autoimmune pancreatitis: Studies 
in mice overexpressing a dominant negative mutant from 
of the TGF-  receptor in the pancreas show an increase 
in MHC class 2 molecules, increased susceptibility to ce-
rulein-induced pancreatitis displaying T- and B-cell hy-
peractivation, IgG-type autoantibodies against acinar 
cells and IgM autoantibodies against pancreatic ductal 
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epithelial cells. Mice overexpressing a dominant negative 
mutant form of the TGF-  receptor also display a loss of 
growth inhibitory and gene induction responses, indicat-
ing that TGF-  negatively controls acinar cell growth and 
is vital for the maintenance of a differentiated acinar phe-
notype in vivo  [50] . 
 IL-1 is a proinfl ammatory cytokine predominantly re-
leased from macrophages causing fever, hypotension and 
anorexia. Clinical symptoms after IL-1 administration 
resemble those after TNF-  treatment and are diffi cult to 
discriminate. The effects are probably due to the activa-
tion of neutrophils and the increase of adhesion mole-
cules on leukocytes as well as endothelial cells. Norman 
et al.  [51] utilized a homozygous knockout of the ICE gene 
which is necessary to process pro-IL-1 intracellulary. In a 
model of choline-defi cient, ethionine-supplemented diet, 
the lack of IL-1 production increases survival from 24 to 
80%. Interestingly, IL-1 mRNA production is not altered 
in these knockout mice. Another study of this group using 
transgenic mice with an IL-1 receptor deletion even re-
ports 30–50% greater levels of IL-1 mRNA in knockouts 
as compared to wild-type animals  [52] . A negative feed-
back loop between the IL-1 receptor and gene expression 
is suggested. In addition, the genetic absence of the recep-
tor in IL-1 receptor knockout mice as well as a pharma-
cologic blockade with a recombinant receptor antagonist 
resulted in an attenuated pancreatitis and lower IL-6 lev-
els  [53] . 
 A wide range of cells including macrophages/mono-
cytes, endothelial cells, fi broblasts and smooth muscle 
cells, expresses IL-6. Release of IL-6 is also observed after 
stimulation with IL-1 and TNF-  . This cytokine causes 
pyrexia, stimulates the production and release of acute 
phase proteins with levels of IL-6 peaking 24 h before 
those of acute phase proteins. IL-6 is elevated in patients 
with acute pancreatitis and levels correlate with the sever-
ity of the disease  [54] . In animal studies, the effects of 
IL-6 are controversial: In transgenic mice expressing hu-
man IL-6, the pancreatic wet weight induced by cerulein 
was signifi cantly higher compared with wild-type mice, 
but pretreatment with a specifi c anti-IL-6 receptor anti-
body did not reduce interstitial edema. When cerulein 
was administered with LPS, the pancreatic wet weight 
increased much more as compared to pancreatitis after 
cerulein alone. Pretreatment with the anti-IL-6 receptor 
antibody reduced the pancreatic edema only in human-
IL-6 transgenic mice. The authors of this study concluded 
that anticytokine antibodies might be effective in im-
proving acute pancreatitis  [55] . 
 On the other hand, studying the effects of endogenous 
IL-6 in pancreatitis, Cuzzocrea et al.  [56] utilized IL-6 
knockout mice in a model of cerulein-induced pancreati-
tis. They showed that such knockout mice have higher 
plasma levels of TNF-  and IL-1  , a higher degree of 
oxidative and nitrosative tissue damage, more severe tis-
sue injury and an increased mortality rate as wild-type 
animals. The authors suggested that IL-6 might in fact be 
an anti-infl ammatory cytokine. It is conceivable that gene 
deletion of IL-6 results in an upregulation of TNF-  as a 
compensatory mechanism and therefore it is an impor-
tant proinfl ammatory cytokine. 
 IL-10 is a potent anti-infl ammatory cytokine, which 
inhibits infl ammatory cytokine release from many tis-
sues. Hepatic cytokine release from Kupffer cells (KC) is 
an important source of infl ammatory cytokines and thus 
may contribute to lung damage in acute pancreatitis. To 
investigate the specifi c role of IL-10, knockout mice were 
generated and pancreatitis was induced with or without 
blockade of KC activity. For induction of pancreatitis, 
animals were fed a choline-defi cient, ethionine-supple-
mented diet and gadolinium chloride to inhibit KC activ-
ity. KC blockade has neither an effect on the degree of 
edema in knockout mice, nor on neutrophil infi ltration 
and histological lung changes. All effects are more severe 
in knockout animals as compared to C57BL/6J mice 
proving that IL-10 is important in reducing lung injury 
after induction of acute pancreatitis. Also, KC-derived 
cytokines seem to be of minor importance as compared 
to those derived from other tissues  [57] . 
 New approaches were undertaken to elucidate the in-
tracellular pathways of cytokine action in pancreatitis. 
One hypothesis states that TNF-  and IL-6 are regulated 
via the p38/MK2 pathway. Thus, knockout or inhibition 
of p38 or MK2 would result in lower levels of those cyto-
kines and consequently in a less severe pancreatitis. We 
studied this hypothesis in MK2 knockout mice using the 
model of cerulein-induced pancreatitis. The knockout 
mice showed drastically reduced IL-6 and TNF-  serum 
levels and a marked histological protection with lacking 
infl ammatory cells against pancreatitis as compared to 
control animals. These data support the concept that re-
duction of IL-6 and TNF-  levels ameliorates secreta-
gogue-induced pancreatitis and suggest that the p38 and 
MAPKAP-2 pathway is hereby essential  [58] . 
 Not only cytokines, but also their receptors play a piv-
otal role in pancreatitis. To assess the independent in vivo 
activities of the p75TNF receptor, transgenic mice were 
generated expressing this receptor constitutively with dis-
ease-relevant levels compared to wild-type human 
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p75TNF-R. Studies with such mice revealed that activa-
tion of this receptor triggers a severe multi-organ infl am-
matory syndrome. Similarly to the prolonged NF  B acti-
vation observed in peripheral blood mononuclear cells 
(PBMC) from human septic patients and shown to cause 
pathology in models of endotoxemia, NF  B-binding ac-
tivity was found constitutively increased in PBMC from 
hup75TNF-R transgenic mice suggesting an in vivo role 
for the p75TNF-R in triggering this pathogenic cascade. 
Interestingly, the severity of pathologic changes develop-
ing in the human p75TNF-R transgenic mice correspond-
ed to the levels of soluble p75TNF-R measured in the sera 
of these animals. This refl ected the quantitative correla-
tion between levels of human soluble p75TNF-R produc-
tion and severity of human disease. Remarkably, the 
pathogenic potential of this receptor was even shown in 
the absence of its known ligands, TNF or lymphotoxin-  
and independently of the presence of the p55TNF-R. 
These results established an independent role for induced 
production of the p75TNF-R in the pathogenesis of in-
fl ammation and suggest that antagonizing the receptor 
function may generally be benefi cial in infl ammation 
 [59] . 
 Other Proinfl ammatory Systems 
 Other intra- and extracellular mediators have been dis-
covered in addition to cytokines altering the course of 
pancreatitis. In a study with intercellular adhesion mol-
ecule 1 (ICAM-1) knockout animals, Frossard et al.  [60] 
discovered that lung injury as well as pancreatic injury is 
ameliorated but not abolished. Interestingly, a combina-
tion of this gene knockout with neutrophil depletion left 
the severity of infl ammation in both organs grossly unal-
tered. On the other hand, it was hypothesized that neu-
trophils recruited to the pancreas during pancreatitis may 
contribute to intrapancreatic activation of digestive en-
zymes. To test this, Gukovskaya et al.  [61] used mice de-
fi cient in either nicontinamide adenine dinucleotide 
phosphate (NADPH) oxidase or myeloperoxidase (MPO). 
Mice defi cient in NADPH oxidase showed attenuation of 
the cerulein-induced trypsin activation, but those defi -
cient in MPO did not. Biochemical measurements re-
vealed that the NADPH oxidase resides in neutrophils 
and not in pancreatic acinar tissue. This indicates a role 
for neutrophils infi ltrating the pancreas with pathologic 
activation of digestive enzymes. In addition, the products 
of NADPH oxidase probably mediated the effects. 
 The activation and traffi cking of infl ammatory cells 
involves chemokines. Complement, neutrophils and 
TNF-  are involved in the manifestation of pancreatitis-
associated lung injury. Using a gene-targeting approach, 
Gerard et al.  [62] investigated the role of chemokines in 
pancreatitis and pancreatitis-associated lung injury. De-
letion of the   -chemokine receptor CCR1 in mice result-
ed in reduced pancreatic MPO activity while the severity 
of the pancreatitis was unaffected in the pancreas. How-
ever, CCR1-defi cient mice showed a marked protection 
from pulmonary infl ammation secondary to acute pan-
creatitis. The protection was accompanied with decreased 
levels of TNF-  in a temporal sequence. These results 
indicate that activation of the CCR1 receptor is an early 
event in the systemic infl ammatory response. 
 Cyclooxygenase-2 (Cox-2) plays an important role in 
infl ammation and catalyzes the rate-limiting step in pros-
taglandin synthesis. More recently, two groups showed 
independently that inhibition of Cox-2 using pharmaco-
logical compounds or mice defi cient for Cox-2 amelio-
rates the severity of pancreatitis and pancreatitis-associ-
ated lung injury  [63, 64] . In addition, Ethridge et al.  [64] 
demonstrated that these effects are specifi c for COX-2 
while genetic deletion of the Cox-1 gene had no protective 
effect. 
 Beside Cox-2 as a known proinfl ammatory enzyme, 
the neurokin substance P has been shown to impact on a 
variety of infl ammatory processes. Bhatia et al.  [65] 
showed increased levels of substance P and enhanced ex-
pression of the corresponding neurokinin-1 receptor 
(NK1R) during cerulein-induced pancreatitis. To further 
evaluate the role of substance P, these groups generated 
mice that genetically lacked NK1R and induced pancre-
atitis by administration of cerulein. In these mice, pan-
creatitis and pancreatitis-associated lung injury were at-
tenuated signifi cantly compared to wild-type NK1R 
mice. This indicates that substance P acts via the NK1R 
receptor and plays a proinfl ammatory role in regulating 
the severity of acute pancreatitis. 
 Most recently, further neuropeptides have been dis-
covered to enhance pancreatitis in mice. Deletion of the 
preprotachykinin-A gene, a precursor of substance P and 
neurokinin-A, completely protects against pancreatitis-
associated lung injury and partially protects against local 
pancreatic damage in mice  [66] . 
 Complement activation seems also to play a crucial 
role in the process of infl ammation. Complement activa-
tion involves subsequent proteolytic events generating 
fragments with individual signaling properties. C5a is the 
product of proteolysis of C5 and is considered an anaphy-
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lotoxin. Bhatia et al.  [67] studied animals lacking either 
C5 or C5a receptors. These animals exhibit a greater se-
verity of pancreatitis and associated lung injury as com-
pared to wild-type animals indicating that C5 has an anti-
infl ammatory effect in pancreatitis. 
 There are several known proteins which infl uence the 
infl ammatory cascade of acute pancreatitis. The role of T 
lymphocytes in the pathogenesis of acute experimental 
pancreatitis is only poorly characterized. To further shed 
light onto this, Demols et al.  [68] used nude mice and in 
vivo CD4 +  or CD8 +  T-cell-depleted mice. Nude mice 
showed a signifi cant reduction in the severity of acute 
pancreatitis (approximately 3-fold) compared to wild-
type controls and T lymphocytes transferred to nude mice 
restored the severity of the pancreatitis. Among T lym-
phocytes, CD4 +  T cells play a major role because in vivo 
depletion by anti-CD4Mab administration to wild-type 
mice reduces the severity of pancreatitis to a similar ex-
tent as observed in nude mice, whereas CD8 +  depletion 
does not affect the course of acute pancreatitis. 
 The specifi c role of phospholipase A 2  in acute pancre-
atitis is still unclear. To further resolve its role in the 
pathogenesis of acute pancreatitis, Mayer et al.  [69] gen-
erated mice expressing human group IIA phospholipase 
A 2  and examined the severity of pancreatitis compared 
to C57/bl (wild-type) mice. After pancreatitis induction 
with a choline-defi cient, ethionine-supplemented diet, no 
differences in the severity of pancreatitis were found. 
This study argues against group IIA phospholipase A 2  as 
an important factor for the severity of experimental pan-
creatitis. 
 In conclusion, the discussed data demonstrate that 
with the help of transgenic animal models and other mo-
lecular approaches, new insights in the pathophysiology 
of acute pancreatitis have been gained. Transgenic mod-
els are essential to elucidate pathophysiological processes 
in the development and maintenance of pancreatitis. 
Those transgenic approaches range from structural pro-
teins over zymogen granule proteins like the GTPase 
Rab3D and Itmap1 to proteases like cathepsin B as well 
as Hsps, cytokines, and MAP kinases. These data imply 
new therapeutic strategies for patients at risk with acute 
pancreatitis, for example after ERCP, with anticytokine 
antibodies or protease inhibitors. In addition, other phar-
macological tools like specifi c kinase inhibitors and anti-
bodies appear promising in the treatment and prevention 
of pancreatitis. 
 Despite all the advantages coming from transgenic an-
imal models, the transfer to the clinical situations is 
doubtful. 
 Interactions between proteins, genes and overlapping 
effects remain unconsidered in transgenic animals. Espe-
cially in infl ammatory processes the cascades of activa-
tion are probably more complex. One transgene might be 
up- or downregulating or simply modulate several pro-
cesses at the same time. Infl ammatory actions induce 
events in which not just one factor activates the subse-
quent downstream protein. Rather, one factor is often 
regulated by many upstream elements, sometimes only 
through interaction of several factors at the same time. 
One transgene does not necessarily inhibit or induce the 
next downstream mediator on its own. Therefore, trans-
genic models reduce processes often to a hypothetical lin-
ear cascade that does not mirror the complex regulatory 
pathways in infl ammation. 
 It will still be a great challenge to understand the com-
plex interactions between proteins and genes leading to 
pancreatitis. The transgenic animals of the next generation 
would ideally take those interactions into consideration 
and double transgenes might help in understanding the 
underlying processes. With the Cre/ loxP system a new 
transgenic tool is available with the ability both to overex-
press proteins in specifi c tissues and to eliminate their ex-
pression in selected sites. Cre is the product of the cycla-
tion recombination gene of bacteriophage P1. This en-
zyme recognizes loxP (locus of X-over of P1) and excises 
the genetic region fl anked by loxP. By specifi c placement 
of loxP sites into the intron of a target gene, a functionally 
‘normal’ mouse, yet carrying the loxP sites, is created. By 
mating this mouse with another mouse, which expresses 
Cre under a specifi cally designed promoter (tissue specifi c 
and or inducible), the target gene is activated in vivo. 
 As compared to conventional knockout mouse mod-
els, the Cre/loxP system represents a model of condition-
al mutagenesis with the novel advantage of an organ- or 
cell-specifi c activation or ablation of a target gene. When 
designed with an inducible promoter, the gene of interest 
can be expressed in a timely controlled mode, too. This 
technology renders new and promising progress in the 
elucidation of the pathophysiology of acute pancreatitis. 
 In the fi eld of pancreatic cancer, fi rst research results 
have been reported by Grippo et al.  [70] with Cre expres-
sion under an elastase promoter-activating TNF-  ex-
pression and by Aguirre et al.  [71] studying a pancreas-spe-
cifi c Cre-mediated activation of a mutant K-ras allele and 
the deletion of the tumor suppressor allele Ink4a/Arf. 
 The Cre/loxP system has so far not been established 
widely to clarify the development and perpetuation of 
acute pancreatitis. There is certainly need for these induc-
ible gene-targeting studies to clarify the pathophysiology 
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of acute pancreatitis, for example by creating an inducible 
NF  B model to further evaluate the role of NF  B in this 
disease. Even though animal models are an essential step 
in the translational process of research, only clinical stud-
ies will ultimately verify the importance of the results. 
 Because of space limitations, this review cannot claim 
completeness of all transgenic animal studies in experi-
mental pancreatitis. However, it points out the major re-
sults in this fi eld. 
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